What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?

Focosi, Daniele; Tuccori, Marco; Antonelli, Guido; Maggi, Fabrizio

Focosi, Daniele; Tuccori, Marco; Antonelli, Guido; Maggi, Fabrizio.

Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: daniele.focosi@gmail.com.
Tuccori M; Division of Pharmacovigilance, Pisa University Hospital, Pisa, Italy.
Antonelli G; Laboratory of "Microbiology and Virology", Department of Molecular Medicine, University Hospital "Policlinico Umberto I" Sapienza University, Rome, Italy.
Maggi F; Division of Virology, University of Pisa, Pisa, Italy.

Clin Microbiol Infect ; 27(2): 163-165, 2021 Feb.

Article in English | MEDLINE | ID: covidwho-1176608

Subject(s)

Blood Donors; COVID-19/therapy; Plasma; COVID-19/economics; Clinical Trials as Topic; Humans; Immunization, Passive/economics; Immunization, Passive/standards; COVID-19 Serotherapy

Keywords

Convalescent plasma; Coronavirus disease 2019; Hyperimmune serum; Severe acute respiratory syndrome coronavirus 2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasma / Blood Donors / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google